Literature DB >> 17699441

Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007.

Andrew S Levey1, Sharon P Andreoli, Thomas DuBose, Robert Provenzano, Allan J Collins.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17699441     DOI： 10.2215/CJN.04041206

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  World incidence of AKI: a meta-analysis.

Authors:  Paweena Susantitaphong; Dinna N Cruz; Jorge Cerda; Maher Abulfaraj; Fahad Alqahtani; Ioannis Koulouridis; Bertrand L Jaber
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

2.  Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.

Authors:  Catherina A Cuevas; Alexis A Gonzalez; Nibaldo C Inestrosa; Carlos P Vio; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-19

3.  Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.

Authors:  Ananda Chapagain; Paul W Caton; Julius Kieswich; Petros Andrikopoulos; Nanda Nayuni; Jamie H Long; Steven M Harwood; Scott P Webster; Martin J Raftery; Christoph Thiemermann; Brian R Walker; Jonathan R Seckl; Roger Corder; Muhammad Magdi Yaqoob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-25       Impact factor: 11.205

4.  Prevalence of chronic kidney disease risk factors among low birth weight adolescents.

Authors:  Dev Darshan K Khalsa; Hind A Beydoun; J Bryan Carmody
Journal:  Pediatr Nephrol       Date:  2016-04-27       Impact factor: 3.714

5.  Renal replacement therapy in Ukraine: epidemiology and international comparisons.

Authors:  Inna Kolesnyk; Marlies Noordzij; Mykola Kolesnyk; Mykola Kulyzky; Kitty J Jager
Journal:  Clin Kidney J       Date:  2014-04-24

6.  Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.

Authors:  Sunil Bhandari; Natalie Ives; Elizabeth A Brettell; Marie Valente; Paul Cockwell; Peter S Topham; John G Cleland; Arif Khwaja; Meguid El Nahas
Journal:  Nephrol Dial Transplant       Date:  2015-09-30       Impact factor: 5.992

Review 7.  Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice.

Authors:  Luca De Nicola; Luca Di Lullo; Ernesto Paoletti; Adamasco Cupisti; Stefano Bianchi
Journal:  J Nephrol       Date:  2018-06-07       Impact factor: 3.902

8.  Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study.

Authors:  K Mukendi; F B Lepira; J R Makulo; K E Sumaili; P K Kayembe; M N Nseka
Journal:  Cardiovasc J Afr       Date:  2015 May-Jun       Impact factor: 1.167

9.  Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease.

Authors:  Ezra Gabbay; Itzchak Slotki; Linda Shavit
Journal:  BMC Nephrol       Date:  2015-08-07       Impact factor: 2.388

10.  Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.

Authors:  Zaher Armaly; Amir Abd El Qader; Adel Jabbour; Kamal Hassan; Rawi Ramadan; Abdalla Bowirrat; Bishara Bisharat
Journal:  BMC Nephrol       Date:  2015-08-13       Impact factor: 2.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.